2024 Q3 Form 10-Q Financial Statement

#000149315224030835 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $206.0K $234.3K
YoY Change -74.22% -50.51%
Cost Of Revenue $8.317M $8.685M
YoY Change 45.99% 31.12%
Gross Profit $5.003M $3.651M
YoY Change 5.04% -11.68%
Gross Profit Margin 2428.69% 1558.14%
Selling, General & Admin $5.207M $7.268M
YoY Change -19.47% 56.36%
% of Gross Profit 104.08% 199.06%
Research & Development $2.597M $1.840M
YoY Change -17.1% -20.44%
% of Gross Profit 51.9% 50.39%
Depreciation & Amortization $138.5K $136.8K
YoY Change -15.16% -39.1%
% of Gross Profit 2.77% 3.75%
Operating Expenses $16.12M $17.79M
YoY Change 5.39% 30.98%
Operating Profit -$2.801M -$5.456M
YoY Change -42.08% 93.06%
Interest Expense -$540.7K -$484.4K
YoY Change -83.82% -342.62%
% of Operating Profit
Other Income/Expense, Net -$534.5K -$465.6K
YoY Change -83.83% -296.69%
Pretax Income -$3.335M -$5.922M
YoY Change -59.03% 128.69%
Income Tax $125.0K
% Of Pretax Income
Net Earnings -$3.460M -$5.922M
YoY Change -57.7% 125.29%
Net Earnings / Revenue -1679.91% -2527.28%
Basic Earnings Per Share -$0.03 -$0.05
Diluted Earnings Per Share -$0.03 -$0.05
COMMON SHARES
Basic Shares Outstanding 121.0M shares 118.4M shares
Diluted Shares Outstanding 124.3M shares 121.4M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.24M $17.63M
YoY Change 41.19% -40.46%
Cash & Equivalents $14.53M $10.04M
Short-Term Investments $21.71M $7.587M
Other Short-Term Assets $2.697M $3.111M
YoY Change 28.8% 81.74%
Inventory $6.555M $5.650M
Prepaid Expenses
Receivables $9.234M $7.406M
Other Receivables $0.00 $0.00
Total Short-Term Assets $63.00M $40.32M
YoY Change 37.2% -13.84%
LONG-TERM ASSETS
Property, Plant & Equipment $2.016M $2.143M
YoY Change 12.0% 17.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.129M $3.982M
YoY Change -32.35% -48.47%
Other Assets $124.9K $124.9K
YoY Change -26.14% -26.14%
Total Long-Term Assets $7.576M $8.728M
YoY Change -19.77% -31.43%
TOTAL ASSETS
Total Short-Term Assets $63.00M $40.32M
Total Long-Term Assets $7.576M $8.728M
Total Assets $70.58M $49.05M
YoY Change 27.48% -17.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.386M $5.714M
YoY Change -32.6% 48.93%
Accrued Expenses $13.69M $13.42M
YoY Change 110.13% 129.22%
Deferred Revenue $268.5K $198.3K
YoY Change -51.62% -72.4%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $43.95M $45.35M
YoY Change 194.76% 285.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.619M $1.494M
YoY Change 16.42% 9.76%
Total Long-Term Liabilities $1.619M $1.494M
YoY Change 16.42% 9.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.95M $45.35M
Total Long-Term Liabilities $1.619M $1.494M
Total Liabilities $47.85M $49.26M
YoY Change 146.18% 196.29%
SHAREHOLDERS EQUITY
Retained Earnings -$400.1M -$396.6M
YoY Change 14.57% 16.3%
Common Stock $1.533M $1.156M
YoY Change 38.85% 5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost) $103.2K $103.1K
YoY Change 0.05% 0.0%
Treasury Stock Shares
Shareholders Equity $22.73M -$216.3K
YoY Change
Total Liabilities & Shareholders Equity $70.58M $49.05M
YoY Change 27.48% -17.6%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$3.460M -$5.922M
YoY Change -57.7% 125.29%
Depreciation, Depletion And Amortization $138.5K $136.8K
YoY Change -15.16% -39.1%
Cash From Operating Activities -$6.457M -$3.077M
YoY Change 69.13% -26.29%
INVESTING ACTIVITIES
Capital Expenditures $10.27K $65.17K
YoY Change -92.34% -69.91%
Acquisitions
YoY Change
Other Investing Activities -$14.24M -$639.0K
YoY Change -360.62% 63800.0%
Cash From Investing Activities -$14.25M -$704.2K
YoY Change -367.37% -95.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.20M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -6.457M -3.077M
Cash From Investing Activities -14.25M -704.2K
Cash From Financing Activities 25.20M 0.000
Net Change In Cash 4.486M -3.781M
YoY Change 196.31% -1266.05%
FREE CASH FLOW
Cash From Operating Activities -$6.457M -$3.077M
Capital Expenditures $10.27K $65.17K
Free Cash Flow -$6.467M -$3.142M
YoY Change 63.66% -28.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
usd
KOPN Increase Decrease In Provision For Credit Losses
IncreaseDecreaseInProvisionForCreditLosses
usd
KOPN Increase Decrease In Accrued Litigation Damages
IncreaseDecreaseInAccruedLitigationDamages
usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
usd
KOPN Issuance Of Common Stock Net Of Costs
IssuanceOfCommonStockNetOfCosts
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-3327347 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23990615 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
194190 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6227 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21335000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21335000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-2628555 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42897477 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42897477 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1191257 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17750 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-8180379 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35926105 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35926105 usd
us-gaap Profit Loss
ProfitLoss
-38470213 usd
us-gaap Profit Loss
ProfitLoss
-10808934 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
332155 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
387779 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1411346 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1385449 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
78210 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-38633 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-51950 usd
KOPN Increase Decrease In Provision For Credit Losses
IncreaseDecreaseInProvisionForCreditLosses
790950 usd
KOPN Noncash Provision For Excess Inventory
NoncashProvisionForExcessInventory
1023709 usd
KOPN Noncash Provision For Excess Inventory
NoncashProvisionForExcessInventory
292405 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
734243 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
2887893 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-513556 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-198194 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2994914 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1565340 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
3353456 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
96923 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-912158 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1685961 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
857448 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
929086 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4474548 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1396840 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-738047 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-375499 usd
KOPN Increase Decrease In Accrued Litigation Damages
IncreaseDecreaseInAccruedLitigationDamages
24800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6183902 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7992073 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
310600 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
350631 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1119012 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17624779 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5250066 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
6466917 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
483 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3820454 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11508976 usd
KOPN Issuance Of Common Stock Net Of Costs
IssuanceOfCommonStockNetOfCosts
7242581 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21335000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7242581 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21335000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3029 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13839 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4882162 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1847790 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6210685 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8258878 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11092847 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10106668 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_804_eus-gaap--BasisOfAccounting_zuFFtOpvv049" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82E_zLNpBNTP5T3">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements of Kopin Corporation as of June 29, 2024 and for the three and six month periods ended June 29, 2024 and July 1, 2023 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements for the three and six month periods ended June 29, 2024 and July 1, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231230_z51Mmdfg7bYi" title="Net losses">19.7</span> million and net cash outflows from operations of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20231230_z771w8J06pp7" title="Net cash outflows from operations">15.3</span> million for the fiscal year ended 2023. The Company incurred a net loss of $<span id="xdx_908_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240629_zWKl8PSskC0e" title="Net losses">38.5</span> million for the six months ended June 29, 2024 and net cash outflows from operations of $<span id="xdx_909_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20231231__20240629_zE127hZNPTM5" title="Net cash outflows from operations">6.2</span> million. This net loss of $<span id="xdx_90E_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240629_zBvMT0fp9fAf" title="Net losses">38.5</span> million includes an estimated $<span id="xdx_905_ecustom--EstimatedPossibleDamagesAmount_pn5n6_c20231231__20240629_zBuq3jSC2sYi" title="Estimated possible damages amount">24.8</span> million of possible damages related to a jury verdict which is explained below. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable debt securities over the last several years, which was primarily a result of funding operating losses. As described in Note 14 Litigation, on April 22, 2024, a jury verdict was entered against the Company awarding approximately $<span id="xdx_90D_eus-gaap--LitigationSettlementLoss_pn5n6_c20240422__20240422_z5jfnbpCSpM2" title="Damages settlement">5.1</span> million in damages as well as recommending $<span id="xdx_908_eus-gaap--PaymentsForLegalSettlements_pn5n6_c20240422__20240422_zvTj3KYs7cLg" title="Exemplary damages">19.7</span> million in disgorgement and exemplary damages. On May 22, 2024, the Company filed its Motion for Judgment as a Matter of Law or in the alternative for a New Trial, as well as two submissions arguing that the disgorgement and exemplary damages should not be awarded. That same day, BlueRadios filed motions seeking a permanent injunction prohibiting Kopin from selling any products that incorporate BlueRadios’ trade secrets, over $<span id="xdx_907_eus-gaap--PrepaidInterest_iI_pn6n6_c20240522_zUHT8LM4LDzf" title="Pre-judgment interest">10</span> million in pre-judgment interest, and over $<span id="xdx_90B_eus-gaap--LegalFees_pn6n6_c20240522__20240522_zsYfICvpGnW4" title="Attorneys fees and costs">10</span> million in attorneys’ fees and costs. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues. The Company is also considering the appeal of any award in a final judgment. The Company had $<span id="xdx_902_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20240629_zdqcRGNrMX4a" title="Cash and cash equivalents, restricted cash, and marketable debt securities">18.7</span> million of cash and cash equivalents, restricted cash, and marketable debt securities at June 29, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has historical and current negative cash flow from operations and limited liquidity resources. The Company’s current strategy is to continue to invest in its business and raise additional capital through financing activities that may include public offerings and private placements of its common stock, preferred stock offerings, collaborations and licensing arrangements and issuances of debt and convertible debt instruments. Until such time that additional capital can be raised, the Company plans to strategically manage its uncommitted spend, execute its priorities and implement cost saving measures to reduce research and development and general and administrative expenditures which could include minimizing staff costs. The Company may also sell assets and look at other strategic alternatives. There are inherent uncertainties associated with fundraising activities and activities to manage our uncommitted spending and the successful execution of these activities may not be within the Company’s control. There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company is unable to achieve positive cash flows and profitability in the foreseeable future, cannot successfully raise additional capital and implement its strategic plan, or the recommended disgorgement and exemplary damages are not significantly reduced or eliminated in the final order, the Company’s liquidity, financial condition and business prospects will be materially and adversely affected. There is substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-19700000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-38500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-38500000 usd
KOPN Estimated Possible Damages Amount
EstimatedPossibleDamagesAmount
24800000 usd
CY2024Q2 us-gaap Litigation Settlement Loss
LitigationSettlementLoss
5100000 usd
CY2024Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
19700000 usd
CY2024Q2 us-gaap Prepaid Interest
PrepaidInterest
10000000 usd
CY2024Q2 us-gaap Legal Fees
LegalFees
10000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
18700000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1100000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
8119150 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12250204 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-32136 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-58204 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8087014 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12192000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
7120181 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
966833 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8087014 usd
CY2024Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
18892823 usd
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
21960127 usd
CY2024Q2 us-gaap Investments
Investments
5200000 usd
CY2023Q3 us-gaap Payments For Royalties
PaymentsForRoyalties
400000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3100000 usd
CY2023Q3 us-gaap Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
2500000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
700000 usd
CY2024Q2 us-gaap Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
1800000 usd
CY2024Q2 us-gaap Other Investments
OtherInvestments
2000000.0 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8394272 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10731036 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
988000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1025000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7406272 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9706036 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1025000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
37000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
988000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
3479654 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4785197 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1379528 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2018421 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
790483 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
798188 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
5649665 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7601806 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5489028 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3989161 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5489028 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3989161 shares
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3080000 shares
CY2024Q1 KOPN Gross Proceeds From Registered Sale Equity Securities
GrossProceedsFromRegisteredSaleEquitySecurities
7466755 usd
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.42
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
17000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1931767 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
4131820 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
328100 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
246459 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.00
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5489028 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.32
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
676418 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1191258 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1411346 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1385449 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
676418 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1191258 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1411346 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1385449 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7200000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
us-gaap Extended Product Warranty Description
ExtendedProductWarrantyDescription
The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2160000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
694000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
180000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2674000 usd
CY2024Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0.0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0.0 usd
CY2023Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
122700000 usd
KOPN Operating Loss Carryforwards Expiring Date
OperatingLossCarryforwardsExpiringDate
expiring 2024 through 2038
CY2024Q2 KOPN Operating Loss Carryforwards Unlimited
OperatingLossCarryforwardsUnlimited
107000000.0 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6523002 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3409809 usd
us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract
3113193 usd
CY2024Q2 KOPN Percentage Of Change In Contract Assets Current
PercentageOfChangeInContractAssetsCurrent
0.91 pure
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
198291 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
916826 usd
KOPN Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract
718535 usd
CY2024Q2 KOPN Percentage Contract Liabilities And Billings In Excess Of Revenue Earned
PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned
-0.78 pure
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3920 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23198 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
19278 usd
CY2024Q2 KOPN Percentage Of Change In Contract Liabilitiesnoncurrent
PercentageOfChangeInContractLiabilitiesnoncurrent
-0.83 pure
CY2024Q2 KOPN Net Contract Assets Liabilities
NetContractAssetsLiabilities
6320791 usd
CY2023Q4 KOPN Net Contract Assets Liabilities
NetContractAssetsLiabilities
2469785 usd
KOPN Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
3851006 usd
CY2024Q2 KOPN Percentage Of Change In Net Contract Assets Liabilities
PercentageOfChangeInNetContractAssetsLiabilities
1.56 pure
CY2024Q2 KOPN Net Contract Assets
NetContractAssets
3900000 usd
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
31600000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
205743 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
217863 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
433370 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
432426 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
426743 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
763994 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
732610 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
669255 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
201333 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2793935 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
335876 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2458059 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
672038 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1786021 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2458059 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
432612 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
496691 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0679 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600 pure
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M10D
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
4621000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
4668000 usd
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
4621000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
4668000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12336000 usd
CY2024Q2 KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10460000 usd
CY2023Q3 KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22369000 usd
KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21218000 usd
KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12336000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10460000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22369000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21218000 usd
CY2024Q2 us-gaap Loss Contingency Damages Sought
LossContingencyDamagesSought
On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues.
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10000000 usd
CY2024Q2 us-gaap Payments For Fees
PaymentsForFees
10000000 usd
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
5100000 usd
KOPN Loss Contingency Exemplary Damages Sought Value
LossContingencyExemplaryDamagesSoughtValue
19700000 usd
CY2024Q2 us-gaap Revenues
Revenues
234323 usd
CY2024Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
97305 usd
CY2023Q3 us-gaap Revenues
Revenues
798901 usd
CY2023Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
168800 usd
us-gaap Revenues
Revenues
441633 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
186655 usd
us-gaap Revenues
Revenues
1272401 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
208055 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
231999 usd
CY2024Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
64155 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
144915 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
97600 usd

Files In Submission

Name View Source Status
0001493152-24-030835-index-headers.html Edgar Link pending
0001493152-24-030835-index.html Edgar Link pending
0001493152-24-030835.txt Edgar Link pending
0001493152-24-030835-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
kopn-20240629.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
kopn-20240629_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
kopn-20240629_def.xml Edgar Link unprocessable
kopn-20240629_lab.xml Edgar Link unprocessable
kopn-20240629_pre.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable